文献速递银屑病与炎症性皮肤病

生物制剂治疗儿童斑块状银屑病的管理

Management of pediatric plaque psoriasis using biologics.
PubMed 文献 · J Am Acad Dermatol · 2019-05-29

本文综述了生物制剂治疗儿童中重度斑块状银屑病的现有数据,并提出了一个临床相关的治疗算法。加拿大专家小组通过迭代过程制定推荐,涵盖基线筛查和持续监测,强调治疗选择需考虑合并症、生活质量及安全性。

要点

  • 生物制剂可用于儿童中重度斑块状银屑病,治疗目标为皮损清除或几乎清除。
  • 提出基于生物制剂的治疗算法,并给出基线筛查与监测建议。
  • 治疗选择应结合患者合并症、生活质量影响及安全性,与照护者共同决策。

核心结论

  • 提出了儿童中重度斑块状银屑病的生物制剂治疗算法,并提供了基线筛查和持续监测的指导。

研究设计与样本

  • 加拿大专家小组综述现有生物制剂数据及儿童银屑病临床情况,通过迭代过程制定共识推荐。

主要发现

  • 生物制剂在儿童中重度斑块状银屑病中可实现皮损清除或几乎清除的目标。
  • 治疗选择需考虑患者合并症、生活质量影响及安全性方面。

关键数值与推荐

  • 推荐采用包含已批准生物制剂的治疗算法进行管理。
  • 建议进行基线筛查和持续监测。

临床怎么用

  • 临床中可依据该算法为儿童中重度斑块状银屑病选择生物制剂,并规范基线筛查与监测。
  • 治疗决策应与患者及其照护者共同讨论,结合合并症、生活质量及安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a chronic inflammatory disease with clinical manifestations of the skin that affect adults and children. In adults, biologics have revolutionized the treatment of moderate to severe plaque psoriasis where clear or almost clear is a tangible goal. Research on biologics has recently been extended to children. The introduction of these new therapeutic options has outpaced the limited guidelines in this population. OBJECTIVE: To provide a review of current data on biologics, with a proposal for a clinically relevant treatment algorithm on the management of moderate to severe plaque psoriasis in the pediatric population. METHODS: A Canadian panel with expertise in psoriasis, pediatric dermatology, and experience with consensus recommendation processes was selected to review the current landscape of pediatric psoriasis and clinical data on biologics plus identify special considerations for baseline workup and monitoring. Recommendations were reviewed and edited by each expert in an iterative process. CONCLUSION: A treatment algorithm for moderate to severe plaque psoriasis in pediatric patients is presented, incorporating approved biologics. Guidance on baseline screening and ongoing monitoring is also provided. Ultimately, treatment choice depends on the patient and his or her caregiver, with consideration of comorbidities, impact on quality of life, and relevant safety aspects.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Lansang P, Bergman JN, Fiorillo L, et al. Management of pediatric plaque psoriasis using biologics. J Am Acad Dermatol. 2019. PMID: 31150699. doi:10.1016/j.jaad.2019.05.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。